Encompass Health Corporation Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31)
Encompass Health Corporation (EHC) reported Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) of $13.40 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss · last filed 2020-02-27
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-12-31 was $2.50M, a 46.81% decline year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $2.30M, a 43.90% decline year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $3.70M, a 24.49% decline year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2019-03-31 was $4.90M, a 44.12% increase year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2019 was $13.40M, a 21.64% decline from fiscal 2018.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2018 was $17.10M, a 0.59% increase from fiscal 2017.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2017 was $17.00M, a 17.07% decline from fiscal 2016.
- Encompass Health Corporation equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for fiscal 2016 was $20.50M, a 8.47% increase from fiscal 2015.
| Period end | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 3 month as first filed | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.80M derived: sum of 2 quarters · filed 2020-02-27 | $8.50M derived: sum of 3 quarters · filed 2020-02-27 | $13.40M 10-K · filed 2020-02-27 | |
| 2019-09-30 | $2.30M 10-Q · filed 2019-10-31 | $6.00M derived: sum of 2 quarters · filed 2019-10-31 | $10.90M 10-Q · filed 2019-10-31 | $15.60M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2019-06-30 | $3.70M 10-Q · filed 2019-07-31 | $8.60M 10-Q · filed 2019-07-31 | $13.30M derived: sum of 3 quarters · filed 2020-02-27 | $17.40M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2019-03-31 | $4.90M 10-Q · filed 2019-05-01 | $9.60M derived: sum of 2 quarters · filed 2020-02-27 | $13.70M derived: sum of 3 quarters · filed 2020-02-27 | $18.60M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.80M derived: sum of 2 quarters · filed 2020-02-27 | $13.70M derived: sum of 3 quarters · filed 2020-02-27 | $17.10M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $4.10M 10-Q · filed 2019-10-31 | $9.00M derived: sum of 2 quarters · filed 2019-10-31 | $12.40M 10-Q · filed 2019-10-31 | $16.50M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $4.90M 10-Q · filed 2019-07-31 | $8.30M 10-Q · filed 2019-07-31 | $12.40M derived: sum of 3 quarters · filed 2020-02-27 | $16.70M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $3.40M 10-Q · filed 2019-05-01 | $7.50M derived: sum of 2 quarters · filed 2020-02-27 | $11.80M derived: sum of 3 quarters · filed 2020-02-27 | $16.20M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.40M derived: sum of 2 quarters · filed 2020-02-27 | $12.80M derived: sum of 3 quarters · filed 2020-02-27 | $17.00M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $4.30M 10-Q · filed 2018-10-31 | $8.70M derived: sum of 2 quarters · filed 2018-10-31 | $12.90M 10-Q · filed 2018-10-31 | $18.40M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $4.40M 10-Q · filed 2018-08-02 | $9.00M 10-Q · filed 2018-08-02 | $14.10M derived: sum of 3 quarters · filed 2019-02-27 | $19.30M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $4.40M 10-Q · filed 2018-05-02 | $9.70M derived: sum of 2 quarters · filed 2019-02-27 | $14.90M derived: sum of 3 quarters · filed 2019-02-27 | $19.90M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $10.50M derived: sum of 2 quarters · filed 2019-02-27 | $15.50M derived: sum of 3 quarters · filed 2019-02-27 | $20.50M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $5.20M 10-Q · filed 2017-10-31 | $10.20M derived: sum of 2 quarters · filed 2017-10-31 | $15.20M 10-Q · filed 2017-10-31 | $20.30M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $5.00M 10-Q · filed 2017-08-02 | $10.00M 10-Q · filed 2017-08-02 | $15.10M derived: sum of 3 quarters · filed 2018-02-28 | $20.20M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $5.00M 10-Q · filed 2017-04-28 | $10.10M derived: sum of 2 quarters · filed 2018-02-28 | $15.20M derived: sum of 3 quarters · filed 2018-02-28 | $20.00M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $10.20M derived: sum of 2 quarters · filed 2018-02-28 | $15.00M derived: sum of 3 quarters · filed 2018-02-28 | $18.90M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $5.10M 10-Q · filed 2016-10-28 | $9.90M derived: sum of 2 quarters · filed 2016-10-28 | $13.80M 10-Q · filed 2016-10-28 | $16.50M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-06-30 | $4.80M 10-Q · filed 2016-07-29 | $8.70M 10-Q · filed 2016-07-29 | $11.40M derived: sum of 3 quarters · filed 2017-09-19 | $15.60M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-03-31 | $3.90M 10-Q · filed 2016-04-28 | $6.60M derived: sum of 2 quarters · filed 2017-09-19 | $10.80M derived: sum of 3 quarters · filed 2017-09-19 | $16.30M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2014-12-31 | $2.70M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $6.90M derived: sum of 2 quarters · filed 2017-09-19 | $12.40M derived: sum of 3 quarters · filed 2017-09-19 | $30.90M 8-K · filed 2017-09-19 | |
| 2014-09-30 | $4.20M 10-Q · filed 2015-10-29 | $9.70M derived: sum of 2 quarters · filed 2015-10-29 | $28.20M 10-Q · filed 2015-10-29 | $34.40M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $5.50M 10-Q · filed 2015-07-30 | $24.00M 10-Q · filed 2015-07-30 | $30.20M derived: sum of 3 quarters · filed 2016-02-25 | $34.60M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $18.50M 10-Q · filed 2015-05-01 | $24.70M derived: sum of 2 quarters · filed 2016-02-25 | $29.10M derived: sum of 3 quarters · filed 2016-02-25 | $36.40M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $10.60M derived: sum of 2 quarters · filed 2016-02-25 | $17.90M derived: sum of 3 quarters · filed 2016-02-25 | $24.60M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $4.40M 10-Q · filed 2014-10-28 | $11.70M derived: sum of 2 quarters · filed 2014-10-28 | $18.40M 10-Q · filed 2014-10-28 | $25.20M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $7.30M 10-Q · filed 2014-07-29 | $14.00M 10-Q · filed 2014-07-29 | $20.80M derived: sum of 3 quarters · filed 2015-03-02 | $27.90M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $6.70M 10-Q · filed 2014-04-29 | $6.60M 10-Q · filed 2013-04-26 | $13.50M derived: sum of 2 quarters · filed 2015-03-02 | $20.60M derived: sum of 3 quarters · filed 2015-03-02 | $27.50M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $13.90M derived: sum of 2 quarters · filed 2015-03-02 | $20.80M derived: sum of 3 quarters · filed 2015-03-02 | $28.30M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $7.10M 10-Q · filed 2013-10-29 | $14.00M derived: sum of 2 quarters · filed 2013-10-29 | $21.50M 10-Q · filed 2013-10-29 | $28.40M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-06-30 | $6.90M 10-Q · filed 2013-07-30 | $14.40M 10-Q · filed 2013-07-30 | $21.30M derived: sum of 3 quarters · filed 2014-02-20 | $28.30M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-03-31 | $7.50M 10-Q · filed 2013-04-26 | $14.40M derived: sum of 2 quarters · filed 2014-02-20 | $21.40M derived: sum of 3 quarters · filed 2014-02-20 | $28.40M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2011-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $13.90M derived: sum of 2 quarters · filed 2014-02-20 | $20.90M derived: sum of 3 quarters · filed 2014-02-20 | $26.50M 10-K · filed 2014-02-20 | |
| 2011-09-30 | $7.00M 10-Q · filed 2012-10-26 | $14.00M derived: sum of 2 quarters · filed 2012-10-26 | $19.60M 10-Q · filed 2012-10-26 | $25.50M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-06-30 | $7.00M 10-Q · filed 2012-07-27 | $12.60M 10-Q · filed 2012-07-27 | $18.50M derived: sum of 3 quarters · filed 2013-02-19 | $23.80M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-03-31 | $5.60M 10-Q · filed 2012-05-01 | $11.50M derived: sum of 2 quarters · filed 2013-02-19 | $16.80M derived: sum of 3 quarters · filed 2013-02-19 | $22.70M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2010-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $11.20M derived: sum of 2 quarters · filed 2013-02-19 | $17.10M derived: sum of 3 quarters · filed 2013-02-19 | $23.00M 10-K · filed 2013-02-19 | |
| 2010-09-30 | $5.30M 10-Q · filed 2011-11-04 | $11.20M derived: sum of 2 quarters · filed 2011-11-04 | $17.10M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $5.90M 10-Q · filed 2011-08-04 | $11.80M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $20.50M 8-K · filed 2012-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |